Mattel announced the release of the first-ever Barbie doll with type 1 diabetes, complete with a continuous glucose monitor and an insulin pump in Barbie's signature pink.

Insulin aspart was the second rapidly acting analogue introduced, approved for clinical use in Europe in 1999 and by the FDA in 2000 for patients with Type 1 or Type 2 diabetes.

Lilly's once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trials ...

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to fasting blood glucose levels. A fixed-dose regimen of insulin efsitora alfa ...

Type 1 diabetes (T1D) is an autoimmune condition where the immune system destroys insulin-producing β-cells in the pancreas. Yet, not all patients lose insulin function at the same pace ...

Meat may dominate the protein conversation, but plant-based options like tempeh could be your best bet for improving insulin sensitivity.

How cellular quality control contributes to insulin resistance related to type 2 diabetes Date: May 4, 2025 Source: Pennington Biomedical Research Center Summary: Researchers have revealed ...

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label updates for 2025.

Both a 3-mL single-patient-use prefilled pen and a 10-mL multiple-dose vial are included in this approval. Serious side effects reported with Merilog include hypoglycemia, severe allergic ...

The agency has given a thumbs up to Sanofi’s Merilog (insulin-aspart-szjj) as the first biosimilar to Novo Nordisk’s NovoLog for patients with diabetes.

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and children with diabetes, the agency announced Friday.

With a balanced blend of whole grains, fiber and protein, this breakfast can help support steady energy and stable blood sugar levels.